These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 917446)

  • 1. HLA antigens in bronchogenic carcinoma.
    Sengar DP; McLeish WA; Stewart TH; Harris JE
    Oncology; 1977; 34(4):143-5. PubMed ID: 917446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HL-A antigens in bronchogenic carcinoma].
    Sengar DP; McLeish WA; Stewart TH; Harris JE
    Onkologie; 1978 Apr; 1(2):63-5. PubMed ID: 362283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA-A, B antigens and bronchogenic pulmonary carcinoma].
    Prazák J; Mĕricka O
    Cas Lek Cesk; 1987 Aug; 126(34):1081-2. PubMed ID: 3478139
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antigens and bronchogenic carcinoma in the Greek population.
    Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
    Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens and bronchogenic carcinoma.
    Prazák J; Mĕricka O
    Neoplasma; 1989; 36(5):599-602. PubMed ID: 2812153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA type and survival in lung cancer.
    Weiss GB; Nawrocki LB; Daniels JC
    Cancer; 1980 Jul; 46(1):38-40. PubMed ID: 7388766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study.
    Rogentine CN; Dellon AL; Chretien PB
    Cancer; 1977 Jun; 39(6):2345-7. PubMed ID: 872033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical relevancy of cellular immunity in bronchogenic carcinoma].
    Muhrer KH; Filler D; Schwemmle K; Gierhake FW
    Prax Klin Pneumol; 1982 Aug; 36(8):335-9. PubMed ID: 7134160
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoprofile studies for patients with bronchogenic carcinoma--I: correlation of pre-therapy studies with stage of diseases.
    Concannon JP; Dalbow MH; Eng CP; Conway J
    Int J Radiat Oncol Biol Phys; 1977; 2(5-6):447-54. PubMed ID: 301875
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
    Alsabti EA
    Oncology; 1979; 36(4):171-5. PubMed ID: 157453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
    Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
    Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
    Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
    Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
    Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological studies in bronchogenic carcinoma].
    Zeromski J
    Pol Tyg Lek; 1973 May; 28(22):836-8. PubMed ID: 4722196
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological examination of patients with bronchogenic carcinoma (author's transl)].
    Foltýnová V; Mostecký H; Dienstbier Z; Hlavatý V; Koprivová H; Rezný Z
    Sb Lek; 1980 Mar; 82(3):89-96. PubMed ID: 7367805
    [No Abstract]   [Full Text] [Related]  

  • 17. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic studies in bronchogenic carcinoma.
    Zeromski J
    Ann Med Sect Pol Acad Sci; 1974; 19(3-4):197-236. PubMed ID: 4616524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of radiotherapy on the immunocompetence in patients with bronchogenic carcinoma and laryngeal cancer (author's transl)].
    Oshitani T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(9):873-86. PubMed ID: 7335479
    [No Abstract]   [Full Text] [Related]  

  • 20. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma.
    Pierce GE; Allingham R; Bell JW
    Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.